RAB1A and neoplasm: Overexpression of Rab1A is correlated with a poor prognosis and has been proposed to promote tumor progression by activating the mTORC1 signaling pathway in CRC and HCC, indicating that Rab1A might be a valuable therapeutic target for personalized therapy [8].